Percocet is generally considered slightly stronger than Norco on a milligram-for-milligram basis. Percocet contains oxycodone paired with acetaminophen, while Norco combines hydrocodone with the same acetaminophen. Standard dosing guides treat oxycodone as roughly one-and-a-half times more potent than hydrocodone, but the real-world difference is more nuanced than that ratio suggests. Head-to-head lab studies, genetics research, and long-term outcome data all complicate the simple “which is stronger” question in ways that matter for anyone weighing one prescription against the other.
What Head-to-Head Studies Actually Show
Surprisingly few studies have put oxycodone and hydrocodone side by side at equal doses and measured pain relief directly. One of the more carefully designed comparisons gave healthy participants either 10 mg of oxycodone/acetaminophen or 10 mg of hydrocodone/acetaminophen. The oxycodone combination produced a wider range of measurable subjective effects and stronger pupil constriction (a physiological marker of opioid activity) than the hydrocodone combination at the same dose. Both impaired psychomotor performance equally at that 10 mg level.1PubMed Central. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products
A separate study among prescription opioid abusers tested the relative potency of oxycodone, hydrocodone, and hydromorphone at various doses. The researchers concluded that oxycodone was roughly equipotent to or slightly more potent than hydrocodone, and that the abuse-liability profiles of the three drugs did not differ dramatically from each other.2PubMed Central. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers That phrase “roughly equipotent to slightly more potent” captures the state of the evidence well: oxycodone edges out hydrocodone, but the gap is not as wide as many patients assume.
The practical takeaway is that at the doses you would actually be prescribed, the difference in raw painkilling strength between a Percocet and a Norco tablet is modest. A Norco 10/325 (10 mg hydrocodone, 325 mg acetaminophen) and a Percocet 5/325 (5 mg oxycodone, 325 mg acetaminophen) are often treated as roughly comparable prescriptions. When doctors choose between them, the decision usually rests on factors beyond potency alone.
Why Your Genetics Can Flip the Answer
Both oxycodone and hydrocodone are processed through liver enzymes that vary a lot from person to person, and these variations can make one drug feel dramatically stronger or weaker than expected. Hydrocodone relies heavily on two enzymes: CYP2D6 converts it into hydromorphone (a more potent metabolite), while CYP3A4 converts it into norhydrocodone (a much less active one).3PubMed Central. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes Oxycodone follows a similar enzymatic path. If your CYP2D6 enzyme works sluggishly, you convert less of either drug into its active metabolite, and pain relief suffers.
A large study of over 8,000 patients quantified what this looks like in practice. People who were “poor metabolizers” (meaning their CYP2D6 enzyme was genetically slower) experienced significantly less pain reduction from opioids and needed higher doses to achieve the same effect as normal metabolizers. Across all pain-severity groups, poor metabolizers had worse pain scores at every time point measured. They also ended up receiving about 50 percent more morphine-equivalent dosing to try to compensate.4PubMed. Evaluation of the impact of CYP2D6 testing on outcomes in patients taking opioids
Roughly 5 to 10 percent of people of European descent are poor CYP2D6 metabolizers, and rates vary across other populations. At the other end of the spectrum, ultra-rapid metabolizers convert the drug too fast and can experience exaggerated effects or more severe side effects from a standard dose. This means someone for whom Norco does nothing might respond perfectly well to Percocet, or vice versa, based entirely on their enzyme profile. Pharmacogenomic testing can identify which camp you fall into, though it is still far from routine in most clinical settings.
The Side Effect Trade-Off
Stronger does not automatically mean “more side effects,” but the research leans in that direction for oxycodone. The head-to-head study at equal 10 mg doses found that oxycodone produced a broader array of subjective effects compared to hydrocodone.1PubMed Central. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products In practical terms, this means people taking Percocet are somewhat more likely to report noticeable drowsiness, nausea, and constipation at a given dose compared to Norco. Both drugs share the standard opioid side-effect menu (itching, dizziness, lightheadedness), but patients switching from hydrocodone to oxycodone sometimes notice the jump.
On the other hand, oxycodone’s stronger receptor effects may mean it controls moderate-to-severe pain at a lower absolute dose, which could partially offset those side effects. This is the calculation your prescriber is making: a drug that works at 5 mg instead of 10 mg produces fewer total milligrams of opioid exposure even if, milligram for milligram, it hits harder.
Abuse Liability and How the Drugs “Feel”
One area where oxycodone consistently separates itself from hydrocodone is in how users describe the subjective experience. A review of abuse-liability studies found that oxycodone demonstrated high abuse liability based on elevated “liking” scores and a relative absence of the negative subjective effects that sometimes act as a built-in deterrent with other opioids.5PubMed Central. Likeability and Abuse Liability of Commonly Prescribed Opioids Hydrocodone’s abuse profile, meanwhile, was not consistently distinguishable from morphine’s in the same analysis.
This difference in subjective appeal is one reason regulators have treated the two drugs differently. Until 2014, hydrocodone combination products like Norco sat in Schedule III, a less restrictive category than oxycodone products, which were Schedule II. The DEA reclassified hydrocodone combinations to Schedule II that year, and the change had a measurable effect: claims for hydrocodone combination prescriptions in Medicaid populations dropped at a significantly faster rate afterward compared to other analgesics.6PubMed Central. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population Today, both are Schedule II and subject to the same prescribing restrictions, but the years of looser regulation contributed to hydrocodone becoming one of the most prescribed opioids in the United States.
Long-Term Use and Overdose Risk
An unexpected pattern emerges in long-term prescribing data: despite being the milder drug, hydrocodone appears to lead to longer-term use more often than oxycodone. A primary care study found that roughly 12 percent of patients initially prescribed hydrocodone transitioned to long-term opioid use, compared with about 2 percent of those started on oxycodone. Among patients who received more than one prescription, the gap widened further, to about 23 percent for hydrocodone versus 5 percent for oxycodone.7PubMed Central. Long-term use of hydrocodone vs. oxycodone in primary care
That finding is counterintuitive. One likely explanation is prescribing culture: because hydrocodone was historically seen as the “weaker” and “safer” option, doctors may have been more willing to refill it repeatedly, and patients may have been less alarmed about staying on it. The perception of mildness, in other words, may have facilitated chronic use rather than prevented it.
On the overdose side, oxycodone carries a measurably higher risk per dose. A comparative study of chronic noncancer pain patients found that low-dose oxycodone was associated with a roughly 80 percent greater risk of opioid overdose compared with low-dose hydrocodone. Low-dose oxycodone was also linked to higher rates of opioid use disorder.8PubMed Central. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients The same study found no significant difference in overdose risk between tramadol and hydrocodone, positioning oxycodone as the clear outlier among the three common first-line opioids. These findings track with oxycodone’s slightly higher potency and its more euphoric subjective profile discussed earlier.
Kidney Disease and Older Adults
For older adults and people with kidney problems, the potency comparison takes on additional dimensions. Both drugs and their metabolites are cleared through the kidneys, and when kidney function declines, those metabolites accumulate. Oxycodone’s metabolites build up enough that peak blood concentrations can reach about 50 percent higher than normal in patients with renal failure.9Therapeutics and Clinical Risk Management. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists That effectively makes the drug stronger than intended, raising the risk of sedation and respiratory depression.
A review of opioid management in older adults with chronic kidney disease recommended hydrocodone as a first-line short-acting option for this population and positioned oxycodone as a second-line agent requiring more cautious monitoring. Both drugs should be started at the lowest possible dose, typically 2.5 to 5 mg every four to six hours, and neither should be escalated without close follow-up. Hydrocodone’s metabolites also accumulate in kidney impairment, so neither option is truly “safe” in this group, but hydrocodone gets the slight nod as the more predictable choice.10PubMed Central. Opioid Management in Older Adults with Chronic Kidney Disease: A Review
Oxycodone does have one advantage in kidney patients who undergo hemodialysis: because of its low molecular weight and limited distribution in the body, it tends to be removed during dialysis sessions. That partial clearance can provide a window of reduced drug levels, though it also means pain can break through unexpectedly after treatment.9Therapeutics and Clinical Risk Management. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
The Acetaminophen Ceiling Nobody Talks About
Both Percocet and Norco are combination products, meaning each tablet contains acetaminophen alongside the opioid. This adds a painkilling boost from a completely different mechanism (acetaminophen works centrally rather than at opioid receptors), but it also creates a hidden ceiling. The maximum recommended acetaminophen intake for adults is generally 3,000 to 4,000 mg per day, depending on the guideline and the patient’s liver health. At standard Norco dosing of 10/325 (10 mg hydrocodone, 325 mg acetaminophen), a patient taking one tablet every four hours reaches 1,950 mg of acetaminophen in a day of regular dosing. That leaves some room, but not much if you are also taking other products that contain acetaminophen, like cold medicines or over-the-counter pain relievers.
The acetaminophen component is particularly risky in young children. A study of over 2,600 prescriptions for combination opioid/acetaminophen products in children under 3 years old found that potential acetaminophen overdose occurred in about 0.7 percent of prescriptions, and potential opioid overdose in about 1.6 percent. Children under 3 months faced the highest risk.11PubMed Central. Potential Acetaminophen and Opioid Overdoses in Young Children Prescribed Combination Acetaminophen/Opioid Preparations These numbers are small in percentage terms, but for a serious adverse event they are striking, and they are one reason pediatricians generally try to avoid these combination products in very young patients.
For adults, the practical point is this: if your pain requires escalating doses of either Percocet or Norco, the acetaminophen ceiling may be the binding constraint before the opioid dose itself becomes dangerous. Doctors sometimes switch patients to single-entity oxycodone or hydrocodone (without acetaminophen) when higher opioid doses are needed, which removes the liver-toxicity cap entirely.
When Neither Is the Best Choice
For certain types of acute pain, both Percocet and Norco may be outperformed by non-opioid alternatives. A systematic review and meta-analysis of dental pain studies found that nonsteroidal anti-inflammatory drugs like ibuprofen outperformed oxycodone/acetaminophen combinations for postoperative dental pain, and that certain prescription-strength anti-inflammatories showed significantly greater pain relief.12ScienceDirect / Journal of Dentistry. Efficacy of oxycodone for postoperative dental pain: A systematic review and meta-analysis Dental pain is largely inflammatory, which explains why drugs targeting inflammation directly tend to work better than opioids for it.
This finding extends to other inflammatory pain scenarios. After wisdom tooth removal, for instance, ibuprofen combined with acetaminophen (no opioid at all) has repeatedly matched or beaten opioid-containing regimens for pain control while producing far fewer side effects. The evidence is strong enough that many dental associations now recommend ibuprofen/acetaminophen as the default after extractions, reserving opioids for cases where that combination fails.
Pregnancy and Breastfeeding Considerations
Both hydrocodone and oxycodone cross the placenta, and both enter breast milk. A review of pain medication use during pregnancy found that commonly prescribed analgesics, including opioids, appear relatively safe in terms of major birth defects, though caution is warranted in late pregnancy because of the risk of neonatal withdrawal syndrome and respiratory depression in the newborn.13PubMed Central. Treating pain during pregnancy
Neither Percocet nor Norco is considered clearly safer than the other during pregnancy. The choice usually comes down to using the lowest effective dose for the shortest possible time. During breastfeeding, the same CYP2D6 genetic variability discussed earlier becomes relevant again: a mother who is an ultra-rapid metabolizer can produce unusually high levels of active metabolites that transfer to the infant through milk. Cases of infant sedation and even death have been reported with codeine in ultra-rapid metabolizers, and while the evidence for oxycodone and hydrocodone is less dramatic, the mechanism is the same. Prescribers tend to favor hydrocodone during lactation because of its slightly lower potency and the somewhat greater body of safety data, but close monitoring of both the mother and infant is the real safeguard regardless of which drug is chosen.
What “Stronger” Actually Means for Your Prescription
The question most people are really asking when they search “Is Percocet stronger than Norco?” is whether one will control their pain better. The answer is almost always that both will work, because prescribers adjust the dose to match the drug’s potency. A 5 mg Percocet and a 7.5 or 10 mg Norco produce similar levels of pain relief for most people. The more meaningful differences lie in the territory covered above: oxycodone’s slightly higher overdose risk at equivalent analgesic doses, hydrocodone’s tendency to become a longer-term prescription, the role of genetics in individual response, and the specific population-level concerns around kidney function and age.
If your doctor switches you from one to the other, the conversion is usually straightforward, and you should not expect a dramatic change in how well your pain is controlled. If one drug is not working for you, the explanation is more likely to be genetic metabolism, the type of pain you have, or the dose itself than any fundamental superiority of one molecule over the other.